View the NewsRx Library

Virus Weekly

Free (Library Title)

Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention
Enfer Diagnostics and AnDiaTec Partner to Launch Animal Disease Eradication Technologies Worldwide
Drug warning prompts treatment changes for those infected with hepatitis B and HIV
Researchers pit novel version of common virus against cancer
Ultra deep sequencing identifies HIV drug resistance at early stage
New vaccine prevents CMV infection and disease in mice
A treatment which slows the growth of colon and liver cancers
Fever After Smallpox Vaccination Tied to Individual Genetic Variations
Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
Safety Measures for Oseltamivir Phosphate and Chugai's Future Approach
7NEWS-Suffolk University Poll Reveals Dangerous Disconnect on Universal Health Care
Former President and CEO of Biomira Alex McPherson Joins Carrington Board of Directors
Ludlow China Upgrades China Biopharma, Inc.
Global Summit of Women Launches Consortium to End Cervical Cancer
Panacos Announces Substantial Antiviral Response in Bevirimat 250 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study
Additional Studies Demonstrate PuriCore's Sterilox Solution Effective against Major Outbreak Pathogens
The Anti-Infectives Market Is Forecast To Expand At a CAGR of 4.8% Over the Period 2005-11
HHS Awards Two Contracts to Expand Domestic Vaccine Manufacturing Capacity for a Potential Influenza Pandemic
MedImmune is Awarded Contract by U.S. Department of Health and Human Services to Retrofit Manufacturing Facilities for Production of Pandemic Influenza Vaccines
New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Sanofi pasteur Awarded Contract to Retrofit Influenza Vaccine Facility
Sanofi Pasteur Supports Who Initiative for the Establishment of an H5n1 Vaccine Stockpile
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of the NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
Encorium Group, Inc. Announces $3.8 Million Contract for Phase 2 Clinical Trial in Herpes Zoster (Shingles)


	Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search Copyright © 2008 NewsRx